<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01181908</url>
  </required_header>
  <id_info>
    <org_study_id>113476</org_study_id>
    <nct_id>NCT01181908</nct_id>
  </id_info>
  <brief_title>Alcohol Interaction Study</brief_title>
  <official_title>A Study to Investigate the Psychomotor and Cognitive Effects of Alcohol When Co-administered With GSK1144814 or Matching Placebo in Healthy Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is understand the effects of GSK114814 and alcohol in healthy
      volunteers when taken together.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to investigate the CNS effects of co-administration of
      GSK1144814 with alcohol. Healthy volunteers who meet the eligibility criteria will be
      randomized to receive GSK1144814 or placebo with alcohol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 11, 2009</start_date>
  <completion_date type="Actual">December 30, 2009</completion_date>
  <primary_completion_date type="Actual">December 30, 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pharmacodynamic measures for various psychomotor/cognition function and subjective effects</measure>
    <time_frame>pre and post study drug administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>alcohol level</measure>
    <time_frame>during and post alcohol administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood level of GSK1144814</measure>
    <time_frame>pre and post study drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety and tolerability as measured by adverse events, vital signs, clinical laboratory measurements and validated clinical assessment scales</measure>
    <time_frame>throughout the study pre- and post dose</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Alcoholism</condition>
  <arm_group>
    <arm_group_label>GSK1144814</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive either GSK1144814 or placebo at each treatment arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will receive either GSK1144814 or placebo at each treatment arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>single dose</intervention_name>
    <description>Subjects will receive a single dose of GSK1144814 or placebo.</description>
    <arm_group_label>GSK1144814</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male and female

          -  Body weight 50 kg or higher and BMI within the range 19 - 29.9 kg/m2

          -  Willing to use appropriate contraception methods

        Exclusion Criteria:

          -  Positive HIV, Hepatitis B surface antigen or Hepatitis C antibody result

          -  Any serious medical disorder or condition

          -  Any history of an endocrine disorder.

          -  Any clinically significant laboratory abnormality.

          -  History of psychiatric illness.

          -  Any history of suicidal attempts or behavior.

          -  Positive urine drug screen or positive blood alcohol

          -  Pregnant, nursing or potential to have a child

          -  Past history of alcohol dependence or abuse.

          -  History of increased sensitivity to the effects of alcohol or violent
             behaviour/aggression when intoxicated.

          -  smokers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Leiden</city>
        <zip>2333 CL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>https://gsk-clinicalstudyregister.com/study/113476?search=study&amp;study_ids=113476#rs</url>
    <description>Results for study 113476 can be found on the GSK Clinical Study Register.</description>
  </link>
  <reference>
    <citation>te Beek ET, Hay JL, Bullman JN, Burgess C, Nahon KJ, Klaassen ES, Gray FA, van Gerven JM. Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers. Br J Clin Pharmacol. 2013 May;75(5):1328-39. doi: 10.1111/bcp.12004.</citation>
    <PMID>23067311</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2009</study_first_submitted>
  <study_first_submitted_qc>August 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2010</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alcohol</keyword>
  <keyword>drug interaction</keyword>
  <keyword>pharmacodynamic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

